REPATRIATION MEDICAL AUTHORITY
INSTRUMENT NO. 70 OF 2011
VETERANS’ ENTITLEMENTS ACT 1986
MILITARY REHABILITATION AND COMPENSATION ACT 2004
EXPLANATORY NOTES FOR TABLING
- The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(3) & (8) of the Veterans’ Entitlements Act 1986 (the VEA) Statement of Principles Instrument No. 70 of 2011.
2. This Instrument amends Statement of Principles Instrument No. 45 of 2004 concerning malignant neoplasm of unknown primary site by:
- Replacing existing factor 5(b) with a factor concerning 'ionising radiation';
- Deleting existing factor 5(c) as it is now subsumed by new factor 5(b);
- Re-numbering existing factor 5(d) as 5(c);
- Replacing the existing clause 6 to reflect the changes to the factors;
- Replacing the existing definition of "cumulative equivalent dose" in clause 8; and
- Deleting the definitions of "a course of therapeutic radiation" and "atomic radiation" from clause 8.
3. This Instrument also specifies a date of effect for the amendment in accordance with subsection 12(1)(a) of the Legislative Instruments Act 2003.
4. Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to malignant neoplasm of unknown primary site in the Government Notices Gazettes of 1 September 2010 and 3 November 2010, and circulated a copy of the notices of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants. The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field. No submissions were received for consideration by the Authority during the investigation.
5. The determining of this Instrument finalises the investigation in relation to malignant neoplasm of unknown primary site as advertised in the Government Notices Gazettes of 1 September 2010 and 3 November 2010.
6. A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA. Any such request must be made in writing to the Repatriation Medical Authority at the following address:
The Registrar
Repatriation Medical Authority Secretariat
GPO Box 1014
BRISBANE QLD 4001
Overview
The Repatriation Medical Authority Instrument No. 70 of 2011 amends Statement of Principles Instrument No. 45 of 2004 concerning malignant neoplasm of unknown primary site, as part of the legislative framework established under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This Instrument was enacted to address the need to update and refine the criteria for determining the service-related nature of malignant neoplasm of unknown primary site, particularly in relation to exposure to ionising radiation. The Authority, established under these Acts, undertook an investigation into this condition, advertised in the Government Notices Gazettes, and invited submissions from relevant organisations and experts. No submissions were received, leading to the finalisation of this Instrument, which specifies the date of effect in accordance with the Legislative Instruments Act 2003. This legislative action aims to ensure that the provisions governing the recognition and compensation of service-related health conditions for veterans are current and reflective of the latest medical understanding.
Scope and Application
The Repatriation Medical Authority Instrument No. 70 of 2011 amends the Veterans’ Entitlements Act 1986 concerning malignant neoplasm of unknown primary site, specifically addressing factors related to ionising radiation. This legislative instrument applies to veterans and service personnel, and it is instrumental in determining the criteria and conditions under which claims for medical benefits and compensation can be assessed and approved. The changes to the Statement of Principles reflect an updated understanding of the medical condition in question and aim to provide clarity and fairness in the adjudication of related claims. The instrument’s provisions are applicable nationwide, aligning with the overarching legislative framework provided by the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. Notably, this instrument does not specify any exclusions or exemptions, and its application is comprehensive within the scope of the acts it amends. Subordinate instruments may further extend or restrict its application as needed to address evolving circumstances or new evidence.
Key Provisions
The Repatriation Medical Authority Instrument No. 70 of 2011 amends Statement of Principles Instrument No. 45 of 2004 concerning malignant neoplasm of unknown primary site. Specifically, it replaces existing factor 5(b) with a factor concerning 'ionising radiation', deletes existing factor 5(c) as it is now subsumed by the new factor 5(b), re-numbers existing factor 5(d) as 5(c), updates clause 6 to reflect these changes, replaces the definition of "cumulative equivalent dose" in clause 8, and deletes the definitions of "a course of therapeutic radiation" and "atomic radiation" from clause 8. This Instrument comes into effect in accordance with subsection 12(1)(a) of the Legislative Instruments Act 2003.
The Repatriation Medical Authority is required to consult widely with relevant organisations and individuals before determining this Instrument. This includes advertising the intention to undertake an investigation in the Government Notices Gazettes and circulating notices of intention to investigate to a broad range of organisations representing veterans, service personnel, and their dependants. The Authority must also invite submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the Veterans’ Entitlements Act 1986 (VEA), and any person with expertise in the field. Although no submissions were received in this case, the Authority must still consider any submissions made.
In finalising the investigation, the Repatriation Medical Authority must ensure that all changes to the Statement of Principles are clearly communicated and accessible. Any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA can request a list of references relating to the above condition by making a written request to the Repatriation Medical Authority at the specified address. This ensures transparency and allows for informed feedback and scrutiny.
While the Instrument itself does not detail specific offences, penalties, or consequences for breach, it is part of a larger legislative framework that includes the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. Under these Acts, breaches of legislative requirements or non-compliance with the Authority’s decisions can lead to civil or criminal penalties, including fines and imprisonment, depending on the severity of the breach. The maximum penalties for such breaches are stipulated in the respective Acts and can vary based on the nature and extent of the violation.